Clinical study的問題，透過圖書和論文來找解法和答案更準確安心。 我們找到下列懶人包和總整理

Natural Products and Metabolic Disorders

為了解決Clinical study的問題，作者 這樣論述：

Britt Burton-Freeman, Ph.D. is the Director of Nutrition and Health Promoting Foods platform leader at the Institute for Food Safety and Health at Illinois Institute of Technology. Dr. Freeman has been involved in obesity and metabolic disease research for over 20 years, including basic science and

clinical research in academic, biotechnology and drug development settings. Dr. Freeman’s current research interests are in mitigating disease process through dietary approaches focused on the health promoting properties of whole foods. Specific disease targets are vascular disease and obesity, incl

uding food intake regulation. In her current appointment, she leads a public health initiative with FDA/CFSAN to develop and provide underpinning science for comprehensive approaches using innovative processing solutions to support the availability of safe food with health opportunities. Dr. Freeman

is an active member of multiple professional societies dedicated to health and disease abatement including the American Society for Nutrition, the Obesity Society and the Society for the Study of Ingestive Behavior. Dr. Freeman earned a M.S. and Ph.D. in Nutrition Science with an emphasis in Endocr

inology and Physiological Chemistry at the University of California, Davis.Indika Edirisinghe, Ph.D., Assistant Professor of Food Science and Nutrition at the Institute for Food Safety and Health (IFSH), a research consortium of the United states Food and Drug Administration (FDA) and Illinois Insti

tute of Technology (IIT). He is also the associate Director/ Center for Nutrition Research at IFSH. Dr. Edirisinghe has nearly 15 years experiences in the area of nutritional science, biochemistry and molecular biology. His research focuses on the effect of natural products on endothelial function,

blood pressure regulation, insulin resistance, inflammatory and oxidative stress responses during acute and chronic interventions. The research approach includes human cell culture, animal models and human clinical trials. He has authored over 40 peer reviewed-original research articles and has over

100 total publications including other articles, meeting presentation and book chapters. He is a member of a variety of professional organizations including: The American Society for Nutrition (ASN), The Institute of Food Technologists (IFT) and American Clinical Society (ACS).

Clinical study進入發燒排行的影片

照顧者對於育兒APP使用經驗及滿意度之研究

為了解決Clinical study的問題，作者張可橙 這樣論述：

自2020年COVID-19疫情延燒至今，對家庭帶來很大的生活改變，其中除了育兒日常之外，在防疫期間家庭互動型態也正悄悄地改變。因此，為了解家長育兒實際需求以及使用相關資源是重要的趨勢。家有嬰幼兒的父母需要紀錄各種嬰幼兒的生活紀錄，以確保嬰幼兒的健康狀況及健康檢查，如何善用各項育兒資源，將嬰兒照護資訊化，家長可以即時了解子女目前的狀況。隨著資訊科技進步，智慧型手機的流行，數位工具也愈來愈行動化及便利性，因此針對嬰幼兒各項活動的APP也蓬勃發展。目前市場上育兒APP種類眾多，但深入探討實際使用與功能是否滿足照顧者需求的研究較少。為了解照顧者對於使用育兒APP相關經驗及滿意度為何？研究首先依據文

獻探討嬰幼兒相關文獻，了解行動裝置在嬰幼兒保育相關之領域應用，再將市面上手持行動裝置平台皆有上架的育兒APP，將各個的功能做比較與統整，以問卷調查方式了解照顧者對於育兒APP實際使用情形以及滿意度。本研究採用科技接受模式為研究架構，加入受試者背景變項探討各構面關係，利用SPSS統計分析方法來驗證各項研究假設。研究結果如下：探討照顧者對於育兒APP的使用經驗之現況與差異。「認知有用性」及「認知易用性」會影響「使用意願」；「使用意願」會影響「滿意度」。根據研究結論，提出相對應研究建議，供未來建置應用程式系統可以擴充功能參考，讓使用者滿意度更加提升。

Pediatric and Congenital Cardiology, Cardiac Surgery and Intensive Care

為了解決Clinical study的問題，作者 這樣論述：

Eduardo M. da Cruz is the Associate Medical Director of the Heart Institute, Head of the Pediatric Cardiac Critical Care Program and Director of the Cardiac Intensive Care Section and Inpatient Services at Children’s Hospital Colorado, University of Colorado Denver, School of Medicine. He has had an

international life career in Portugal, Costa Rica, France, United Kingdom, Switzerland and the United States of America. He trained in Medicine and then in Pediatrics at the Universidad de Costa Rica and the Hospital Nacional de Niños in San José, Costa Rica, and then pursued a fellowship in pediat

ric cardiology and intensive care in Paris, France (Hôpital Necker-Enfants Malades, Université René Descartes-Paris V- La Sorbonne). After completing his training, Eduardo stayed in Europe as an attending physician until 2007, when he joined the cardiovascular team at Children’s Hospital Colorado in

Denver, USA, where he currently holds the title of Tenured Professor of Pediatrics, Pediatric Cardiology & Intensive Care. He has close to 30 years of experience in the medical and perioperative management of neonates, children and young adults with complex congenital or acquired heart disease, inc

luding heart transplant, mechanical assistance and quality improvement, safety, clinical effectiveness, stewardship, and crew resource management. He is actively involved in clinical and translational research and teaching in the fields of pediatric cardiology and cardiac intensive care, has deliver

ed close to 300 international lectures, and is a reviewer for 28 peer-reviewed journals, and the Editor or Co-Editor of eight CICU textbooks, including the reference entitled Pediatric and Congenital Cardiology, Cardiac Surgery and Intensive Care (Springer-Verlag UK), a major textbook and e-book/e-r

eference with 6 volumes and close to 4000 pages (Editor-in-Chief) and the first Textbook dedicated to the Intensive Care of Adults with Congenital Heart Disease (Editor-in-Chief). He has published 80 book chapters and more than 100 manuscripts in peer-reviewed journals. He is the Emeritus Founder of

the Working Group on Pediatric Cardiac Intensive Care of the Association for the European Pediatric and Congenital Cardiology (AEPC), Past-Chair and founder of the Section on Pediatric and Congenital Cardiac Intensive Care & Mechanical Circulatory Support of the European Society of Pediatric and Ne

onatal Intensive Care (ESPNIC), a former Board Member of the Congenital Domain of the European Association for Cardio-Thoracic Surgery (EACTS), member of the Society of Pediatric Research (SPR), the European Society of cardiology (ESC) and of multiple other international Societies. Eduardo da Cruz i

s also an Expert Reviewer for the European Commission Horizon 2020 Project, and the President and Chair of the Board of Surgeons of Hope Foundation, a United Nations-affiliated Non-Governmental Organization based in New York, USA. In 2019, he was the recipient of the American College of Cardiology D

istinguished Service Award.Dr. Dunbar Ivy began his medical career at Tulane University School of Medicine following his premedical studies at Davidson College. While at Tulane, he became excited about a career in Pediatric Cardiology under the mentorship of Dr Arthur Pickoff. He then obtained train

ing in General Pediatrics at the University of Colorado School of Medicine in Denver, Colorado. Early mentors in Pediatric Cardiology included Drs. Michael Schaffer and Henry Sondheimer. Interest in altitude related illness and pulmonary hypertension in congenital heart disease were fostered by Dr R

obert Wolfe on the clinical side and Drs Steve Abman and John Kinsella in the fetal sheep laboratory while a fellow in Pediatric Cardiology at the University of Colorado. Following fellowship, he became a research instructor under the guidance of Dr Mark Boucek, who encouraged him to pursue a career

as a clinician scientist. During his time as a Bugher fellow, he obtained early grants from the March of Dimes and American Heart Association regarding the role of endothelin in the perinatal pulmonary circulation. This work transitioned into a National Institutes of Health K-08 award to continue t

o study molecular derangements in the endothelin pathway in models of pulmonary hypertension. In 2003 Dr Ivy took the position of Chief of Pediatric Cardiology and Selby’s Chair of Pediatric Cardiology. His research focus became more clinical and translational. As Director of the Pediatric Pulmonary

Hypertension Program, he began early clinical studies of medical therapy in children, including the use of intravenous epoprostenol, subcutaneous treprostinil, and oral bosentan. He began to work with Dr Robin Shandas regarding measurement of right ventricular afterload in children with pulmonary h

ypertension in an NIH sponsored Specialized Centers of Clinically Oriented Research grant headed by Dr Kurt Stenmark. Further work on ventricular vascular coupling has continued with NIH funding. Dr Ivy was the inaugural Chairman of the first Pediatric Pulmonary Hypertension taskforce at the World S

ymposium of Pulmonary Hypertension in Nice, France in 2013. Dr. Ivy is a member of multiple societies, and has published over 250 peer reviewed manuscripts.Dr. James Jaggers was born and raised in Western Nebraska. He completed medical school at the University of Nebraska Medical Center in Omaha Neb

raska. He then completed General Surgery at the Oregon Health Sciences University in Portland Oregon and Thoracic Surgery training at the University of Colorado Health Sciences Center in Denver, where he also completed a Pediatric Cardiac Surgery Fellowship at The Childrens Hospital In Denver. From

there, his first Faculty position was as assistant professor of Surgery at Duke University Medical Center where he rose to the rank of Associate Professor with tenure and Chief of Pediatric Cardiac Surgery and Director of the Duke Pediatric Heart Institute. During his time as chief of Pediatric Card

iac Surgery at Duke, Dr. Jaggers directed the pediatric cardiovascular surgery laboratory and mentored many research fellows. He was principal and co-principal investigator on two basic Science NIH grants and one Pediatric Heart Network NHLBI sponsored multicenter study. In 2010, Dr. Jaggers moved t

o the University of Colorado and Children’s Hospital Colorado where he is now the Barton Elliman Chair of Congenital Cardiac Surgery and Professor of Surgery. Dr. Jaggers’s Clinical focus is in all areas of Congenital Cardiac Surgery including complex neonatal repairs, single ventricle surgery, hear

t transplantation and surgery for connective tissue disorders. He has special interest in quality, safety and effective care for children. He is also the program director for the University of Colorado’s Congenital cardiac surgery training program. His research interests include Stem cell delivery t

o improve heart function in children with complex congenital heart disease, and laboratory research in investigation into the protein signaling of aortic stenosis and uncompensated cardiac hypertrophy and myocardial dysfunction. Dr. Jaggers is a member of multiple Societies, and has published over 1

40 peer reviewed manuscripts, published 30 book chapters and is a reputed national and international educator and lecturer.

使用理財機器人的行為意圖之研究

為了解決Clinical study的問題，作者林昱德 這樣論述：

本研究以探討使用者使用理財機器人之使用行為相關研究，目的為探討使用者使用因素，提供未來後續業界之參考，以及找出現階段理財機器人使用者的描述性統計分析。本研究以有使用過銀行推出之理財機器人作為研究對象，於 2022年 7月 14日於網路進行正式問卷投放，回收後進行資料分析，經過問卷後台揭露，本次問卷研究投放人數為 4765 人，回收 490 份問卷，有效得 387份，有效回收率為 78.79%。研究架構以 UTAUT2 為基礎，並加入感知風險成為新的會影響使用意圖的因素。研究結果顯示，績效預期、社群影響、促進條件、價格價值以及習慣會對行為意圖產生顯著正向影響；努力預期以及感知風險對行為意圖則是

沒有影響；行為意圖以及習慣對使用行為有顯著正向影響；促進條件對使用意圖則無影響。希冀本研究可以作為相關單位的參考依據。